Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar combined with chemotherapy for stage IV soft tissue sarcoma
NCT03121833Phase 2Completed
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Start
- May 2017
- Primary completion
- Dec 2019
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of endostar in soft tissue sarcoma (STS), sponsored by Tianjin Medical University Cancer Institute and Hospital. Started May 2017; status: completed.
02
Drugs
endostar
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT03121833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03121833.